Monitoring and access |
- Monitor temperature, heart rate and rhythm, SpO2, blood pressure, mean arterial pressure, continuously; monitor urine output, serially.
|
- Insert two large bore intravenous lines. Consider inserting central venous catheter and/or PAC to monitor patient hemodynamics (placement of PAC is particularly important in patients with an ejection fraction <45% or requiring high dose inotropic medication). Insert arterial line.
|
- Obtain echocardiogram for all potential donors. Repeat echocardiogram when patient has stabilized if initial echocardiogram shows significant cardiac dysfunction.
|
- Early flexible bronchoscopy for inspection and airway clearance.
|
Electrolytes |
- Maintain serum Na >135 and <155 mEq/dL.
|
- Maintain serum K >4 and <5 mEq/dL.
|
- Assess serum Mg, Ca, PO4 and replace as needed.
|
- Assess serum lactate and central or mixed venous oxygen saturation.
|
- Correct metabolic acidosis with Na bicarbonate and mild hyperventilation. Aim for arterial pH 7.35 to 7.45.
|
Ventilation |
Initial set-up |
- Mode: Typically, volume control.
|
- Tidal volume: 6 to 8 mL/kg (use ideal predicted body weight¶).
|
- Respiratory rate: 8 to 16 breaths/minute.
|
|
- Initial FiO2: 100%Δ; after stabilization, titrate down to 40%, as tolerated.
|
Adjustments to initial settings |
- Adjust rate and tidal volume to maintain PaCO2 35 to 45 mmHg (4.67 to 6 kPa). Adjust tidal volume, pressure profile, and flow rate to keep peak airway pressure <30 cm H2O.
|
- Titrate FiO2 and PEEP in tandem according to the FiO2/PEEP combinations below to maintain pulse oxygen saturation >95% or PaO2 >90 mmHg (12 kPa).
|
Autonomic storm with hypertension |
- Note, autonomic storm is typically transient. Hypertension and tachycardia should be treated with short-acting agents (eg, esmolol).
|
Goals for resuscitation |
- Normal core body temperature versus mild hypothermia.
|
- Mean arterial pressure ≥60 mmHg.
|
|
|
- SVR 800 to 1200 dynes/second/cm5.
|
- Left ventricular stroke work index >15.
|
- Dopamine dosage <10 mcg/kg/minute.
|
- Urine output ≥1 mL/kg/hour.
|
Volume resuscitation |
- Maintain euvolemia: Assess volume status based on urine output, MAP, CVP, PAOP, and/or dynamic measures (eg, PPV, SPV).
|
- Replete volume with isotonic crystalloids (eg, 0.9% saline, Lactated Ringer solution, Plasma-Lyte, Normosol).
|
Hematologic management |
- Correct abnormal INR or PTT (eg, ≥1.5 times control) with fresh frozen plasma.
|
- Infuse packed RBC to maintain blood hemoglobin >7 mg/dL. A higher pre-procurement hemoglobin may be needed depending on the planned procedure.
|
Vasopressor and inotropic agents |
- After repletion of circulating volume, if MAP <60 mmHg, assess whether cause of hypotension is decreased SVR or decreased cardiac output.
|
- Infuse arginine vasopressin as noted below for decreased SVR.
|
- If MAP remains <60 mmHg and LVEF >45%, add vasopressor agent (eg, norepinephrine, phenylephrine).
|
- If MAP remains <60 mmHg and LVEF <45%, add inotropic agent (eg, dobutamine, dopamine, epinephrine).
|
Hormonal resuscitation |
- Arginine vasopressin: 1 unit bolus intravenously, followed by continuous infusion of 0.01 to 0.04 units/minute, adjusted to maintain MAP >60 mmHg and urinary output 0.5 to 1 mL/kg per hour.
|
- Hydrocortisone 300 mg IV, then 100 mg every 8 hours.
|
- Insulin: There is no universally accepted insulin regimen. To achieve a target blood glucose range (120 to 180 mg/dL), avoid the use of glucose-containing intravenous fluids and administer insulin only when necessary.
|
Renal replacement therapy |
- Continuous renal replacement therapy may be used to facilitate management of severe volume overload, metabolic acidosis, or hyperkalemia in patients with diuretic-refractory oliguric or anuric acute kidney injury.
|
VTE/stress ulcer prevention |
- Low molecular weight heparin (eg, enoxaparin 40 mg SC every 12 hours) for donors with normal kidney function and without active bleeding OR low dose unfractionated heparin SC.
|
- Proton pump inhibitor enterally.
|
Use these FiO2/PEEP combinations to achieve oxygenation goal: |
FiO2 | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 |
PEEP | 5 | 5 to 8 | 8 to 10 | 10 | 10 to 14 | 14 | 14 to 18 | 18 to 24 |